Research in the Lamba Laboratory spans from preclinical basic research to understand mechanisms of resistance to translational research in cancer patients
This evening, we hosted our annual Academic Kickoff at the Reitz Union! This event is an opportunity to welcome our new graduate students, faculty and postdocs to the College and enjoy an evening together 🐊💊
Photos: https://t.co/BXg93XAhHD
Our Hematologic Malignancy, Transplant & Cellular Therapy program is growing! We're seeking applications for a hospitalist in the Division of Hematology & Oncology. The successful candidate will provide inpatient hematology consultations, with a focus on the care of patients with hematologic malignancies and those undergoing transplant and cellular therapy.
Apply today: https://t.co/CO70MlpGZT
The University of Florida has selected physician-scientist Duane A. Mitchell, M.D., Ph.D., as the next director of the UF Health Cancer Institute, a national leader in cancer research and treatment.
Read more: https://t.co/J1CDq5HGUc
UF Health Cancer Institute researchers discovered a new role of a protein in driving AML, then created a duo-targeting PROTAC that effectively killed AML cells.
Read more about the study, published in @oncogenejournal: https://t.co/kvmnBBqgYp
Published in Analytical Chemistry, UF Health Cancer Institute researchers led by @Tim_Garrett1 showed the promise of using paper spray ionization to develop a rapid, noninvasive diagnostic urine test for prostate cancer.
Read the story: https://t.co/PVoxUsq1BN
United by the goal of improving precision medicine, Hematologics Inc and the Lamba Lab collaborated to publish ‘Interstitial Loss of Heterozygosity at Chr19q13 in CD33-Negative AML‘. https://t.co/kajPzWkusS #
Our 2025 annual report highlight's the UF Health Cancer Institute's progress and innovation. With $57.4 million in total cancer grants, we are accelerating cancer research, engaging members in all 16 @UF colleges.
Read the report: https://t.co/ekiBOpVVBN
A record-setting day in so many ways.
120 posters and 15 oral presenters made the #UFPharmacy 39th Annual Research Showcase the biggest yet.
📷 https://t.co/frkejkBZb9
Great presentation by Anna Lux- German PharmD internship trainee from our group at ASH2025 Poster Walk on State of the art AI in Hematology. Congratulations Anna for selection of your abstract for this session and for the amazing presentation!!!👏🏼👏🏼
.@dgkhalaf describes an advancement in AML treatment & disease biology, with a patient-derived CRISPR platform that reveals selective dependencies in AML. Presented today at #ASH25, the UF Health Cancer Institute study is a collaboration led by @LambaLab: https://t.co/jN63TDlBZT
.@LambaLab, co-leader of our Cancer Targeting & Therapeutics research program, is well-represented at #ASH25, with a dozen abstracts. Eight trainees won Abstract Achievement Awards. 👏
Read the abstracts presented at the @ASH_hematology Annual Meeting: https://t.co/bZonHwYWKc
Dina Khalaf, M.D. (@dgkhalaf), a clinical associate professor in the @UFMedicine Division of Hematology and Oncology, is one of our experts attending the @ASH_hematology 67th Annual Meeting and Exposition in Orlando. She shares what she's looking forward to as #ASH25 kicks off.